Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Lixisenatide OD is indicated for the treatment of adults with type 2 diabetes to achieve glycemic control in combination with oral glucose-lowering drugs and/or basal insulin when these, together with diet and exercise, do not provide adequate glycemic control
Loss of C-Kit expression in breast cancer correlates with malignant transformation of breast epithelium and is mediated by kit gene promoter DNA hypermethylation
doi: 10.1002/bip.22072 47 LaoJHansenBCDiMarchiRPocaiA
2 The Clinical Practice Guide was developed by an expert working group comprising representatives from the Australian Diabetes Society (ADS), Australian Diabetes Educators Association (ADEA) and Royal Australian College of General Practitioners (RACGP) and other experts in diabetes care
Missed dose
As a small molecular protein with excellent water solubility and stable biological activity, it has become a core choice for skincare formulation R&D, renowned for its multi-dimensional effects of skin repair, anti-inflammation and anti-aging
